Atropine Sulfate Injection
Product Images NDC 0641-6251

Atropine Sulfate Injection, USP with NDC code 0641-6251-01 is a sterile solution containing 8 mg Atropine sulfate per 20 mL. It is suitable for intravenous, intramuscular, subcutaneous, intraosseous, or endotracheal use. The solution is adjusted with sulfuric acid to achieve a pH of 3.5 (30 to 35). Each mL contains 0.4 mg/mL Atropine sulfate, equivalent to 0.33 mg of atropine. The package comes with 20 single-dose vials. The solution contains benzyl alcohol and sodium chloride, and the instructions recommend referring to the prescribing information for proper dosage. After initial use, the package should be stored at 20°C to 25°C and discarded within two hours to prevent contamination. It is distributed by Hikma Pharmaceuticals and should be used with caution and under medical supervision.*

Atropine Sulfate Injection is a medicine with the National Drug Code (NDC) 0641-6251-10. It is a multiple-dose vial that contains 8mg per 20mL (0.4mg/mL) of Atropine Sulfate, with benzyl alcohol and sodium chloride. It can be used intravenously, intramuscularly, subcutaneously, intraosseously, or endotracheally. Its pH level is 3.5 (3010 3.8), and after the initial use, it should be stored between 20°C to 25°C (68°F to 77°F) and discarded within 24 hours. The usual dosage is indicated in the prescribing information. It is manufactured by Hikma in Berkeley Heights, New Jersey.*

This is a product label that includes a GTIN (Global Trade Item Number) of 0301234567896, a SN (Serial Number) of 1234567890123, an expiration date of MMMYYYY, and a lot number of ABCDE12345. The product details are not specified.*